Epstein Barr Virus (EBV) – Serology
Submission and Collection Notes
Specimens received for EBV Serology will be tested for:
- EBV Viral Capsid Antigen IgG (VCA IgG)
- EBV Early Antigen IgG (EA)
- EBV Nuclear Antigen IgG (EBNA)
Testing for EBV Viral Capsid Antigen IgM (VCA IgM) will be conducted under the following circumstances:
- Upon request by the ordering physician along with clinical information suggesting a recent/current infection. The following information must be included.
- date of onset
- Children under 5 years of age: the following information must be included.
- Date of birth
- Date of onset
Haemolyzed, icteric, lipemic or microbially contaminated sera are not recommended for testing.
Preparation Prior to Transport
Label the specimen container with the patient’s full name, date of collection and one other unique identifier such as the patient’s date of birth or Health Card Number. Failure to provide this information may result in rejection or testing delay.
Centrifuge if using SST. Place specimen in biohazard bag and seal. Specimens should be stored at 2-8°C following collection and shipped to PHOL on ice packs.
Test Frequency and Turnaround Time (TAT)
Epstein Barr Virus serology testing is performed daily Monday to Friday.
Turnaround time is up to 5 days from receipt by PHO Laboratory.
Results are reported to the ordering physician or health care provider as indicated on the requisition.
EBV Serology is tested using a chemiluminescence immunoassay (CLIA).
EBV belongs to the Herpes virus family. Primary EBV infections occur mostly during adolescence with 95% of the population having been infected by age 40. Reactivation to EBV can occur at later times. EBV has been linked with Burkitt’s lymphoma and Nasopharyngeal Carcinoma.
Monoslide/ Monospot is not available at PHO laboratory – contact your private /community lab.